Marine Science & Consulting ApS

 

Quicksearch
from your own companies




Analyst: XBRLDenmark
 
Loading...

Loading...

Loading...

Loading...

 
Loading...

Bankruptcy Risk 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Bankruptcy risk for industry  1.1% 1.1% 1.1% 1.1% 1.1%  
Bankruptcy risk  9.7% 10.2% 10.6% 21.1% 11.6%  
Credit score (0-100)  27 24 22 4 20  
Credit rating  BB BB BB B BB  
Credit limit (kDKK)  0.0 0.0 0.0 -0.0 0.0  

How are these values calculated?
 
View the automatically generated explanation of bankruptcy risk

Income statement (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Gross profit  405 530 420 188 638  
EBITDA  153 124 110 -180 138  
EBIT  57.3 28.4 14.2 -272 75.9  
Pre-tax profit (PTP)  57.3 22.1 6.7 -282.3 64.2  
Net earnings  57.3 32.1 -13.2 -235.8 64.2  
Pre-tax profit without non-rec. items  57.3 22.1 6.7 -282 64.2  

 
See the entire income statement

Balance sheet (kDKK) 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Tangible assets total  346 250 154 62.1 0.0  
Shareholders equity total  117 148 135 -101 -36.7  
Interest-bearing liabilities  263 217 54.0 54.0 54.0  
Balance sheet total (assets)  465 513 455 458 490  

Net Debt  217 -15.8 -24.1 -37.9 -141  
 
See the entire balance sheet

Volume 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6

Net sales  0 0 0 0 0  
Net sales growth  0.0% 0.0% 0.0% 0.0% 0.0%  
Gross profit  405 530 420 188 638  
Gross profit growth  0.0% 30.9% -20.8% -55.2% 239.2%  
Employees  1 1 1 1 1  
Employee growth %  0.0% 0.0% 0.0% 0.0% 0.0%  
Employee expenses  0.0 0.0 0.0 0.0 0.0  
Balance sheet total (assets)  465 513 455 458 490  
Balance sheet change%  0.0% 10.4% -11.4% 0.8% 6.9%  
Added value  153.2 124.3 110.0 -176.3 138.0  
Added value %  0.0% 0.0% 0.0% 0.0% 0.0%  
Investments  250 -192 -192 -184 -124  

Net sales trend  0.0 0.0 0.0 0.0 0.0  
EBIT trend  1.0 2.0 3.0 -1.0 1.0  

Profitability 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
EBITDA %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT %  0.0% 0.0% 0.0% 0.0% 0.0%  
EBIT to gross profit (%)  14.2% 5.4% 3.4% -144.8% 11.9%  
Net Earnings %  0.0% 0.0% 0.0% 0.0% 0.0%  
Profit before depreciation and extraordinary items %  0.0% 0.0% 0.0% 0.0% 0.0%  
Pre tax profit less extraordinaries %  0.0% 0.0% 0.0% 0.0% 0.0%  
ROA %  12.3% 5.8% 2.9% -53.7% 14.0%  
ROI %  15.1% 7.6% 5.1% -224.0% 140.9%  
ROE %  48.8% 24.2% -9.3% -79.5% 13.5%  

Solidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Equity ratio %  25.2% 28.9% 29.7% -18.0% -7.0%  
Relative indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Relative net indebtedness %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net int. bear. debt to EBITDA, %  141.4% -12.7% -21.9% 21.0% -102.1%  
Gearing %  224.3% 146.2% 40.0% -53.6% -147.4%  
Net interest  0 0 0 0 0  
Financing costs %  0.1% 2.6% 5.5% 18.9% 22.1%  

Liquidity 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Quick Ratio  0.3 0.7 0.9 0.7 0.9  
Current Ratio  0.3 0.7 0.9 0.7 0.9  
Cash and cash equivalent  46.3 232.3 78.1 91.9 194.9  

Capital use efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Trade debtors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Trade creditors turnover (days)  0.0 0.0 0.0 0.0 0.0  
Current assets / Net sales %  0.0% 0.0% 0.0% 0.0% 0.0%  
Net working capital  -228.7 -101.9 -19.2 -163.0 -36.7  
Net working capital %  0.0% 0.0% 0.0% 0.0% 0.0%  

Employee efficiency 
2019
2020/6
2020
2021/6
2021
2022/6
2022
2023/6
2023
2024/6
Net sales / employee  0 0 0 0 0  
Added value / employee  153 124 110 -176 138  
Employee expenses / employee  0 0 0 0 0  
EBITDA / employee  153 124 110 -180 138  
EBIT / employee  57 28 14 -272 76  
Net earnings / employee  57 32 -13 -236 64